Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact.
Giacobbe DR, Di Maria E, Tagliafico AS, Bavastro M, Trombetta CS, Marelli C, Di Meco G, Cattardico G, Mora S, Signori A, Vena A, Mikulska M, Dentone C, Bruzzone B, Bignotti B, Orsi A, Robba C, Ball L, Brunetti I, Battaglini D, Di Biagio A, Sormani MP, Pelosi P, Giacomini M, Icardi G, Bassetti M. Giacobbe DR, et al. Among authors: sormani mp. Ann Med. 2023 Dec;55(1):2195204. doi: 10.1080/07853890.2023.2195204. Ann Med. 2023. PMID: 37052252 Free PMC article.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence.
Signoriello E, Lus G, Saccà F, Puthenparampil M, Coppola C, Di Pietro A, Puoti G, Criscuolo MC, Foschi M, Miele G, Abbadessa G, Brescia Morra V, Gallo P, Bonavita S, Sormani MP, Signori A. Signoriello E, et al. Among authors: sormani mp. J Clin Med. 2023 Feb 22;12(5):1768. doi: 10.3390/jcm12051768. J Clin Med. 2023. PMID: 36902555 Free PMC article.
Reliability of patient-reported toxicities during adjuvant chemotherapy.
Cremante M, Pastorino A, Ponzano M, Grassi M, Martelli V, Puccini A, Catalano F, Murianni V, Iaia ML, Puglisi S, Gandini A, Fornarini G, Caprioni F, Andretta V, Pessino A, Comandini D, Sciallero MS, Mammoliti S, Sormani MP, Sobrero A. Cremante M, et al. Among authors: sormani mp. Eur J Cancer. 2023 Mar;182:115-121. doi: 10.1016/j.ejca.2023.01.005. Epub 2023 Jan 14. Eur J Cancer. 2023. PMID: 36758476
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations.
Coerver EM, Kaçar S, Ciccarelli O, Sormani MP, Barkhof F, Arnold DL, Schoonheim MM, Van Kempen ZL, Mostert J, Koch MW, Killestein J, Eshaghi A, Uitdehaag BM, Strijbis EM. Coerver EM, et al. Among authors: sormani mp. Mult Scler. 2024 Sep;30(10):1296-1308. doi: 10.1177/13524585241272938. Epub 2024 Sep 8. Mult Scler. 2024. PMID: 39245991 Free PMC article.
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
Ferraro PM, Filippi L, Ponzano M, Signori A, Orso B, Massa F, Arnaldi D, Caneva S, Argenti L, Losa M, Lombardo L, Mattioli P, Costagli M, Gualco L, Pulze M, Plantone D, Brugnolo A, Girtler N, Diociasi A, Garbarino S, Villani F, Sormani MP, Uccelli A, Roccatagliata L, Pardini M; Alzheimer's Disease Neuroimaging Initiative. Ferraro PM, et al. Among authors: sormani mp. J Alzheimers Dis. 2024 Nov 25:13872877241299843. doi: 10.1177/13872877241299843. Online ahead of print. J Alzheimers Dis. 2024. PMID: 39587787
Utility of icobrain for brain volumetry in multiple sclerosis clinical practice.
Nguyen AL, Sormani MP, Horakova D, Havrdova EH, Barnett MH, De Stefano N, Battaglini M, Vaneckova M, Lui E, Gaillard F, Desmond PM, Prime H, Datta M, Van der Walt A, Jokubaitis VG, Podevyn F, Zivadinov R, Weinstock-Guttman B, D'hooghe MB, Nagels G, Van Pesch V, Laureys G, Van Hijfte L, Lechner-Scott J, Patti F, Cristiano E, Rojas JI, Sima DM, Van Hecke W, Kalincik T, Butzkueven H. Nguyen AL, et al. Among authors: sormani mp. Mult Scler Relat Disord. 2024 Nov 8;92:106148. doi: 10.1016/j.msard.2024.106148. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39536619 Free article.
Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis-A systematic review and meta-analysis.
Heesen C, Röver C, Salem S, Heinz J, Chard D, Rio J, Fittipaldo AV, Lehnert T, Köpke S, Solari A, Sormani MP, Friede T, Rahn AC. Heesen C, et al. Among authors: sormani mp. Mult Scler J Exp Transl Clin. 2024 Oct 24;10(4):20552173241274618. doi: 10.1177/20552173241274618. eCollection 2024 Oct-Dec. Mult Scler J Exp Transl Clin. 2024. PMID: 39493424 Free PMC article. Review.
COVID-19 and multiple sclerosis: challenges and lessons for patient care.
Prosperini L, Arrambide G, Celius EG, Goletti D, Killestein J, Kos D, Lavorgna L, Louapre C, Sormani MP, Stastna D, Ziemssen T, Di Filippo M. Prosperini L, et al. Among authors: sormani mp. Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39429966 Free PMC article. Review.
501 results